Skip to main content
. 2017 Oct 26;8(57):97407–97415. doi: 10.18632/oncotarget.22129

Figure 1. Percentage of BRAF (+/-) with different TgAb concentrations.

Figure 1

When subdivided the TgAb concentration in 20 IU/mL, 40 IU/mL and 115 IU/mL cases, the rates of BRAFV600E mutation declined along with increasing TgAb concentrations.